House Subcommittee Hearing Explores Alleged Gaps In Cosmetic Safety
This article was originally published in The Rose Sheet
Executive SummaryLegislative proposals that would require cosmetics companies to report adverse events to FDA and register their manufacturing facilities were the focus of discussion among panelists testifying on Capitol Hill May 14 on a draft version of the Food and Drug Administration Globalization Act of 2008
You may also be interested in...
Despite repeated stakeholder assertions of being “closer than ever” to modernizing cosmetics regulations, the 115th Congress ended with reform legislation stranded in committee. The Personal Care Products says midterm elections diverted lawmakers’ attention from unresolved issues, likely including possible preemption terms to put a lid on growing state and local requirements.